A site where you can find recommended contractors for non-clinical testing|effical " Non-Clinical CROs and Agencies " Hooke Laboratories, LLC

Hooke Laboratories, LLC

Table of Contents
Table of Contents

Hooke Laboratories, LLC is a U.S. contract research organization (CRO) specializing in non-clinical studies of inflammatory and autoimmune diseases. Known as a manufacturer of high-quality modeling kits, Hooke Laboratories, LLC supports drug discovery research around the world. This article describes in detail the company's service features, disease models, and study examples.

Features of Hooke Laboratories, LLC' Contract Non-clinical Trial Services

Concentration in the area of inflammation and autoimmune diseases

The company concentrates its resources in the area of inflammation and autoimmune diseases, rather than dealing with a broad range of general trials. In particular, the company has accumulated extensive knowledge and experience in models such as multiple sclerosis (EAE) and rheumatoid arthritis (CIA).

This professional background allows us to propose appropriate test systems tailored to the researcher's objectives and challenges. Support that takes into account complex pathomechanisms will help ensure smooth project progress.

Ensure reproducibility by utilizing in-house production kits

For contract testing, we use Hooke Kits™, induction reagents that are quality-controlled and manufactured in-house. By controlling lot differences in the reagents used for testing, we have devised a way to reduce the factors that cause variation from experiment to experiment.

A system that does not rely on externally procured reagents is an important factor in the reproducibility of data. Evaluation under stable conditions provides an objective basis for decision-making in the validation of drug targets.

An example ofHooke Laboratories, LLC' pathological model

Experimental Autoimmune Encephalomyelitis (EAE)

This is the standard model used in multiple sclerosis (MS) research.

Hooke Laboratories, LLC offers multiple EAE models using C57BL/6 and SJL mice. In addition to clinical scoring of neurological symptoms, we can provide detailed evaluation including histological analysis of the spinal cord and immune cells by flow cytometry. This is particularly suitable for drug efficacy evaluation as the incidence and severity of the disease is stable due to our in-house technology.

Reference: Hooke Laboratories, LLC official website
https://hookelabs.com/services/cro/eae.html

Collagen-induced arthritis (CIA)

It is a representative arthritis model that shows pathology similar to human rheumatoid arthritis (RA).

Type II collagen is used to immunize mice (mainly DBA/1 strain) to induce joint swelling and bone destruction, and Hooke Laboratories' CIA model can be used to evaluate limb arthritis scores over time and to analyze joint tissue pathology (inflammatory cell infiltration, bone and cartilage destruction). It is widely used for screening anti-rheumatic drugs.

Reference: Hooke Laboratories, LLC official website
https://hookelabs.com/services/cro/cia.html

Hooke Laboratories, LLC' Non-clinical Case Studies

Ex vivo T cell function analysis

This study is designed to examine in detail the immune response after drug administration.

Using cells from mouse models of disease and immune mice, we evaluate antigen-specific T cell proliferative responses and cytokine production capacity. Using flow cytometry and ELISA, we will determine how the drug affected specific immune pathways. This analysis provides important data that will lead to the elucidation of the mechanism of action (MoA), not just the improvement of symptoms.

Reference: Hooke Laboratories, LLC official website
https://hookelabs.com/services/cro/

Histology/IHC and Pathology Services

This service visually and quantitatively evaluates the degree of inflammation and tissue destruction.

We prepare and analyze pathology specimens of inflammatory cell infiltration and tissue damage (demyelination, bone destruction, etc.) in models of arthritis and encephalomyelitis. In addition to standard HE staining, immunohistochemical staining (IHC) can be used to detect specific proteins and cells. Reading and scoring by an experienced pathologist is an essential component of the reliability of drug efficacy evaluation.

Reference: Hooke Laboratories, LLC official website
https://hookelabs.com/services/cro/

Hooke Laboratories, LLC Company Information

Hooke Laboratories, LLC is a preclinical CRO based in Massachusetts, USA. Specializing in the construction of animal models of inflammatory and autoimmune diseases and the development and manufacture of related products, the company provides high-quality services to pharmaceutical companies and academic institutions worldwide.

Address 439 South Union Street, Lawrence, MA 01843, USA
Tel +1 617 475 5114
Website https://hookelabs.com
3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation
SMC Laboratories, Inc.
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)
  • SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
  • From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.

  • With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.
Safety Studies
Comprehensive Safety Evaluation for FIH Applications
Labcorp Holdings Inc.
(Labcorp Drug Development)
Labcorp Holdings Inc.
Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)
  • Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
  • The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
  • Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.
Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation
PhoenixBio Co., Ltd.
PhoenixBio Co., Ltd.
Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)
  • PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
  • With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.

  • The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

By region
list of animal models
Expertise & Track Record
3 Recommended Contract Non-Clinical Testing Services